CTLA4 and melanoma: All β1, β2, and β3 adrenergic receptors are expressed in peripheral blood monocytes, activated T cells, monocytes, and monocyte-induced dendritic cells, and combinatorial sympathetic and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) blockade can inhibit the growth of murine melanoma [101].